KBR (NYSE:KBR – Get Free Report) issued its quarterly earnings results on Monday. The construction company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.08, Zacks reports. The firm had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2 billion. KBR had a return on equity of 28.87% and a net margin of 4.35%. KBR updated its FY 2025 guidance to 3.710-3.950 EPS.
KBR Stock Down 3.8 %
NYSE KBR opened at $48.29 on Wednesday. The business’s 50-day moving average is $55.82 and its 200 day moving average is $61.69. The stock has a market capitalization of $6.43 billion, a PE ratio of 20.29, a PEG ratio of 0.86 and a beta of 0.83. The company has a debt-to-equity ratio of 1.69, a current ratio of 1.07 and a quick ratio of 1.07. KBR has a 1 year low of $47.19 and a 1 year high of $72.60.
KBR Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Friday, March 14th will be paid a dividend of $0.165 per share. This represents a $0.66 annualized dividend and a dividend yield of 1.37%. This is an increase from KBR’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Friday, March 14th. KBR’s dividend payout ratio is 27.73%.
Wall Street Analyst Weigh In
View Our Latest Analysis on KBR
About KBR
KBR, Inc provides scientific, technology, and engineering solutions to governments and commercial customers worldwide. It operates through Government Solutions and Sustainable Technology Solutions segments. The Government Solutions segment offers life-cycle support solutions to defense, intelligence, space, aviation, and other programs and missions for military and other government agencies in the United States, the United Kingdom, and Australia.
Featured Articles
- Five stocks we like better than KBR
- 3 Warren Buffett Stocks to Buy Now
- Etsy Loses Its Meme Stock Shine – Is It Still a Buy?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Stanley Druckenmiller Bets Big on Airline Stocks – Should You?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
Receive News & Ratings for KBR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KBR and related companies with MarketBeat.com's FREE daily email newsletter.